Eleven Biotherapeutics (EBIO) – Hot FDA News
-
Eleven Biotherapeutics (EBIO) to Partner with AstraZeneca (AZN) & National Cancer Institute on Development of ViciniumTM in Combination with Durvalumab
-
Eleven Biotherapeutics (EBIO) Enters into Exclusive License Agreement with Roche Relating to Interleukin-6 (IL-6) Technology
-
Back to EBIO Stock Lookup
